Weight-loss drug Mounjaro in India: Is it better than Ozempic?

Weight-loss drug Mounjaro in India: Is it better than Ozempic?

US pharmaceutical company Eli Lilly has launched Mounjaro, a diabetes and weight-loss drug, in India. Priced at Rs 3,500 for a 2.5 mg vial, the ‘game-changing’ medication has debuted in the Indian market as the country tackles high rates of obesity and diabetes. But is Mounjaro a better option than Ozempic?

Mounjaro and Ozempic are popular diabetes and weight loss drugs. File Photo/Reuters